Merck Tbk. vs Indo Straits Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Indo Straits Tbk. trades at Rp272 (market cap 147.44B, 33.5K 24h volume). The key difference: Merck Tbk. is far larger — about 11.5× Indo Straits Tbk.'s market cap, and Merck Tbk. is more actively traded (37.6K versus 33.5K). Which is the better fit depends on your goals.
| MERK | PTIS | |
|---|---|---|
Market Cap | 1.7T | 147.44B |
Volume | 37.6K | 33.5K |
Lot | 376 | 335 |
Turnover | 144.47M | 9.03M |
Average Price | 3,842.23 | 269.52 |
Value | 144.47M | 9.03M |
Indicative Equilibrium Price | 3,840 | 268 |
Indicative Equilibrium Volume | 7 | 400 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Read more on PTIS →